Correlation Between Zenicor Medical and Platzer Fastigheter

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zenicor Medical and Platzer Fastigheter at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zenicor Medical and Platzer Fastigheter into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zenicor Medical Systems and Platzer Fastigheter Holding, you can compare the effects of market volatilities on Zenicor Medical and Platzer Fastigheter and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zenicor Medical with a short position of Platzer Fastigheter. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zenicor Medical and Platzer Fastigheter.

Diversification Opportunities for Zenicor Medical and Platzer Fastigheter

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between Zenicor and Platzer is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Zenicor Medical Systems and Platzer Fastigheter Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Platzer Fastigheter and Zenicor Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zenicor Medical Systems are associated (or correlated) with Platzer Fastigheter. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Platzer Fastigheter has no effect on the direction of Zenicor Medical i.e., Zenicor Medical and Platzer Fastigheter go up and down completely randomly.

Pair Corralation between Zenicor Medical and Platzer Fastigheter

Assuming the 90 days trading horizon Zenicor Medical Systems is expected to generate 1.68 times more return on investment than Platzer Fastigheter. However, Zenicor Medical is 1.68 times more volatile than Platzer Fastigheter Holding. It trades about 0.05 of its potential returns per unit of risk. Platzer Fastigheter Holding is currently generating about -0.11 per unit of risk. If you would invest  179.00  in Zenicor Medical Systems on December 26, 2024 and sell it today you would earn a total of  11.00  from holding Zenicor Medical Systems or generate 6.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Zenicor Medical Systems  vs.  Platzer Fastigheter Holding

 Performance 
       Timeline  
Zenicor Medical Systems 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Zenicor Medical Systems are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Zenicor Medical may actually be approaching a critical reversion point that can send shares even higher in April 2025.
Platzer Fastigheter 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Platzer Fastigheter Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Zenicor Medical and Platzer Fastigheter Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zenicor Medical and Platzer Fastigheter

The main advantage of trading using opposite Zenicor Medical and Platzer Fastigheter positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zenicor Medical position performs unexpectedly, Platzer Fastigheter can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Platzer Fastigheter will offset losses from the drop in Platzer Fastigheter's long position.
The idea behind Zenicor Medical Systems and Platzer Fastigheter Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance